Literature DB >> 12538015

Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2).

Stefania Mazzini1, Maria Cristina Bellucci, Rosanna Mondelli.   

Abstract

Berberine, an isoquinoline plant alkaloid, belongs to the structural class of protoberberines. Recently, the ability of these compounds to act as Topoisomerase I or II poisons, was related to the antitumor activity. The binding of protoberberins to DNA has been studied and the partial intercalation into the double helix has been considered responsible for their activity. We have studied the interaction of berberine with the double helix oligonucleotides d(AAGAATTCTT)(2), d(GCGATCGC)(2), d(CGTATACG)(2), d(CGTACG)(2), 5'-d(ACCTTTTTGATGT)-3'/5(ACATCAAAAAGGT)-3' and with the single strand 5'-d(ACATCAAAAAGGT)-3', by 1H, 31P NMR and UV spectroscopy. Phosphorus resonance experiments were performed to detect small conformational changes of the phosphoribose backbone, in the case that an intercalation process occurs. Our data reveal that berberine does not intercalate into the duplexes studied, and binds preferentially to AT rich sequences. The structure of the complex with d(AAGAATTCTT)(2) was determined by using proton 2D NOESY spectra, which allowed to obtain several NOE contacts between the drug and the nucleotide. Structural models were built up by Molecular Mechanics (MM) and Molecular Dynamics (MD) calculations, by using the inter-proton distances derived from the NOE values. Berberine results to be located in the minor groove, lying with the convex side on the helix groove and presenting the positively charged nitrogen atom close to the negative ionic surface of the oligomer. The large 1H chemical shifts variation, observed for the drug when it is added to the above duplexes, as well as to the single strand oligomer, was interpreted with non-specific ionic interactions. The binding constants were measured by UV and NMR spectroscopy. They are strongly affected by the ionic strength and by the self-association process, which commonly occurs with this type of drugs. A dimerisation constant was measured and the value was included in the calculations of the binding constants. The results obtained show that the non-specific ionic interactions represent the major contribution to the values of the binding constants. These parameters, as well as the protons chemical shift variation of the ligand, are thus not diagnostic for the identification of a drug/DNA complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538015     DOI: 10.1016/s0968-0896(02)00466-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Structural studies on ligand-DNA systems: A robust approach in drug design.

Authors:  Surat Kumar; Prateek Pandya; Kumud Pandav; Surendra P Gupta; Arun Chopra
Journal:  J Biosci       Date:  2012-07       Impact factor: 1.826

2.  Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer.

Authors:  Motilal Maiti; Gopinatha Suresh Kumar
Journal:  J Nucleic Acids       Date:  2009-12-15

3.  Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo.

Authors:  Yuchen Cai; Qing Xia; Rongzhen Luo; Peiyu Huang; Yueli Sun; Yanxia Shi; Wenqi Jiang
Journal:  J Nat Med       Date:  2013-04-21       Impact factor: 2.343

4.  G-quadruplex ligands mediate downregulation of DUX4 expression.

Authors:  Lukasz Ciszewski; Ngoc Lu-Nguyen; Alex Slater; Andrew Brennan; Huw E L Williams; George Dickson; Mark S Searle; Linda Popplewell
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

5.  Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box.

Authors:  Yugang Wang; Michael M Kheir; Yushuang Chai; Jun Hu; Dongming Xing; Fan Lei; Lijun Du
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

6.  New aspects of Saccharomyces cerevisiae as a novel carrier for berberine.

Authors:  Roshanak Salari; Bibi Sedigheh Fazly Bazzaz; Omid Rajabi; Zahra Khashyarmanesh
Journal:  Daru       Date:  2013-12-20       Impact factor: 3.117

7.  Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.

Authors:  Mateusz Heldt; Marlena Szeligowska; Majus Misiak; Stefania Mazzini; Leonardo Scaglioni; Grzegorz J Grabe; Marcin Serocki; Jan Lica; Marta Switalska; Joanna Wietrzyk; Giovanni L Beretta; Paola Perego; Dominik Zietkowski; Maciej Baginski; Edward Borowski; Andrzej Skladanowski
Journal:  Oncotarget       Date:  2017-10-10

8.  Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors.

Authors:  Eun-Jin Han; Hyun Young Kim; Naeun Lee; Nam-Hoon Kim; Seung-Ah Yoo; H Moo Kwon; Dae-Myung Jue; Yune-Jung Park; Chul-Soo Cho; Tran Quang De; Dae Young Jeong; Hee-Jong Lim; Woo Kyu Park; Ge Hyeong Lee; Heeyeong Cho; Wan-Uk Kim
Journal:  EBioMedicine       Date:  2017-03-31       Impact factor: 8.143

9.  Evaluation of Analgesic Activity of Papaver libanoticum Extract in Mice: Involvement of Opioids Receptors.

Authors:  Mohamad Ali Hijazi; Ahmed El-Mallah; Maha Aboul-Ela; Abdalla Ellakany
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

10.  Isolation of Oxyberberine and β-Sitosterol from Berberis lycium Royle Root Bark Extract and In Vitro Cytotoxicity against Liver and Lung Cancer Cell Lines.

Authors:  Muhammad Asad Anwar; Shahzadi Tabassam; Muhammad Gulfraz; Muhammad Sheeraz Ahmad; Ghazala Kaukab Raja; Muhammad Arshad
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.